A Study to See Whether a Nutritional Supplement is Beneficial for Patients With Pancreatic Cancer
This study evaluates a nutritional supplement in the treatment of pancreatic cancer in adults. Half of the participants will receive the nutritional supplement, while the other half will receive a placebo.
Pancreatic Cancer
DIETARY_SUPPLEMENT: Nutritional Supplement|DIETARY_SUPPLEMENT: Placebo
Muscle fatty acid content, Quantification of muscle triglyceride fatty acid (ug/g), At time of tumor removal surgery
Plasma levels of the nutritional supplement, Quantification of the plasma concentration of nutritional supplement components (ug/mL), Baseline (before initiation of capsule consumption), day of tumor removal surgery (an average of 2-5 weeks from baseline), and day of post-surgery follow-up CT scan (an average of 8-10 weeks after surgery)|Determine computed tomography (CT)-derived body composition, Quantitatively determine body composition as assessed by computed tomography (CT) scans, relative to stature (cm2/m2), Within 45 days before tumor removal surgery, and day of post-surgery follow-up CT scan (an average of 8-10 weeks after surgery)|Plasma C-reactive protein, Plasma quantification of C-reactive protein (mg/dL), Baseline (before initiation of capsule consumption), day of tumor removal surgery (an average of 2-5 weeks from baseline), and day of post-surgery follow-up CT scan (an average of 8-10 weeks after surgery)
This study evaluates a nutritional supplement in the treatment of pancreatic cancer in adults. Half of the participants will receive the nutritional supplement, while the other half will receive a placebo.